Patents by Inventor Ronald Coutts

Ronald Coutts has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical compositions containing N-propargylphentermine and related analogs to treat neurodegeneration and/or depression
    Patent number: 6593340
    Abstract: The present invention relates to N-propargylphentermine and its derivatives and the neuroprotective and anti-depressant activity of such compounds as well as therapeutic methods for such compounds.
    Type: Grant
    Filed: February 28, 2001
    Date of Patent: July 15, 2003
    Assignee: CV Technologies, Inc.
    Inventors: Brian D. Sloley, Liana Urichuk, Lei Ling, Glen Baker, Ronald Coutts, Jacqueline Shan
  • N.sup.1 -propargylhydrazines, N.sup.2 -propargylhydrazines and their analogs for the treatment of depression, anxiety and neurodegeneration
    Patent number: 6060516
    Abstract: The present invention is directed to novel N.sup.1 -propargylhydrazines, N.sup.2 -propargylhydrazines and their salts in pharmaceutical compositions. The compounds according to the present invention have at least one of the following activities: monoamine oxidase-A inhibiting, monoamine oxidase-B inhibiting, anti-depressant, anti-anxiety and neuroprotectant activities. These compounds are useful as monoamine oxidase inhibitors and should be useful for the treatment of depression, anxiety and of neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease.
    Type: Grant
    Filed: February 17, 1998
    Date of Patent: May 9, 2000
    Assignee: CV Technologies, Inc.
    Inventors: Ronald Coutts, Glen Baker, Duff Sloley, Jacqueline Shan, Peter K. T. Pang